Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)
Clinical trial NCT01208909 · UNKNOWN
Trial details
- NCT number
- NCT01208909
- Sponsor
- University of Zurich
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2009-08-01
- Primary completion
- 2011-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.